<DOC>
	<DOCNO>NCT01383356</DOCNO>
	<brief_summary>The data study use compare kinetic profile metformin 500mg linagliptin/metformin fix dose combination tablet versus Canadian metformin reference product administer concomitantly linagliptin 2.5 mg tablet .</brief_summary>
	<brief_title>Comparison Bioavailability Metformin Between Medium Dose Linagliptin/Metformin Tablets Medium Dose Glucophage Tablet Given With Linagliptin Tablet</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male female subject . Exclusion criterion : 1 . Any relevant deviation healthy condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>